Mesa Laboratories, Inc. (MLAB) To Go Ex-Dividend on May 29th

Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Thursday, April 2nd. Shareholders of record on Friday, May 29th will be paid a dividend of 0.16 per share by the medical instruments supplier on Monday, June 15th. This represents a c) annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, May 29th.

Mesa Laboratories has a payout ratio of 5.2% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Mesa Laboratories to earn $8.74 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 7.3%.

Mesa Laboratories Stock Performance

Shares of NASDAQ MLAB opened at $106.17 on Wednesday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.45 and a current ratio of 1.94. The firm has a market cap of $586.06 million, a price-to-earnings ratio of 165.89 and a beta of 0.94. The business’s 50-day simple moving average is $95.73 and its 200-day simple moving average is $87.51. Mesa Laboratories has a 52 week low of $55.45 and a 52 week high of $115.35.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings data on Wednesday, May 27th. The medical instruments supplier reported $2.76 EPS for the quarter, beating analysts’ consensus estimates of $2.09 by $0.67. The business had revenue of $63.72 million for the quarter, compared to analyst estimates of $65.21 million. Mesa Laboratories had a return on equity of 22.02% and a net margin of 1.51%. As a group, equities research analysts expect that Mesa Laboratories will post 7.26 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MLAB has been the topic of a number of analyst reports. Wells Fargo & Company increased their target price on Mesa Laboratories from $83.00 to $94.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 4th. Wall Street Zen upgraded Mesa Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 7th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Mesa Laboratories in a research note on Monday, May 4th. Two investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus price target of $94.00.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.